Landscape Capital Management L.L.C. Grows Stock Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Landscape Capital Management L.L.C. raised its stake in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 43.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 367,935 shares of the company's stock after acquiring an additional 111,894 shares during the period. Landscape Capital Management L.L.C. owned approximately 0.10% of LifeStance Health Group worth $2,576,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Intech Investment Management LLC acquired a new position in shares of LifeStance Health Group during the 3rd quarter worth $311,000. Jennison Associates LLC raised its holdings in shares of LifeStance Health Group by 9.5% during the 3rd quarter. Jennison Associates LLC now owns 2,136,942 shares of the company's stock worth $14,959,000 after buying an additional 184,896 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of LifeStance Health Group by 6.1% during the 3rd quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company's stock worth $28,817,000 after buying an additional 235,316 shares in the last quarter. Park Edge Advisors LLC acquired a new position in shares of LifeStance Health Group during the 3rd quarter worth $73,000. Finally, SG Americas Securities LLC raised its holdings in shares of LifeStance Health Group by 406.4% during the 3rd quarter. SG Americas Securities LLC now owns 54,532 shares of the company's stock worth $382,000 after buying an additional 43,763 shares in the last quarter. 85.50% of the stock is owned by institutional investors and hedge funds.

LifeStance Health Group Trading Up 1.2 %

Shares of LifeStance Health Group stock traded up $0.09 on Friday, hitting $7.40. 1,515,048 shares of the company's stock traded hands, compared to its average volume of 1,528,602. The company has a market capitalization of $2.83 billion, a price-to-earnings ratio of -28.46 and a beta of 1.24. LifeStance Health Group, Inc. has a one year low of $4.64 and a one year high of $9.20. The company has a fifty day moving average of $7.02 and a two-hundred day moving average of $6.27. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.05. The firm had revenue of $312.70 million during the quarter, compared to the consensus estimate of $302.25 million. LifeStance Health Group had a negative return on equity of 6.66% and a negative net margin of 7.90%. The company's quarterly revenue was up 18.9% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.17) earnings per share. As a group, sell-side analysts expect that LifeStance Health Group, Inc. will post -0.22 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on LFST. Barclays boosted their price target on LifeStance Health Group from $6.00 to $7.00 and gave the stock an "underweight" rating in a report on Monday, November 11th. UBS Group lowered their target price on LifeStance Health Group from $9.00 to $7.50 and set a "neutral" rating for the company in a report on Thursday, August 15th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $8.50.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.